Shares of Tilray dropped by a staggering 25.38% in 30 days from $22.81 to $17.02 at 20:35 EST on Monday, after two consecutive sessions in a row of losses. NASDAQ Composite is dropping 0.48% to $13,895.12, after two consecutive sessions in a row of losses.

Tilray’s last close was $18.34, 293.65% below its 52-week high of $67.00.

Tilray’s Sales

Tilray’s sales growth is 18.7% for the current quarter and 21.8% for the next. The company’s growth estimates for the current quarter and the next is 94.2% and 87.7%, respectively.

Tilray’s Revenue

Year-on-year quarterly revenue growth grew by 19.4%, now sitting on 191.34M for the twelve trailing months.

Tilray’s Stock Yearly Top and Bottom Value

Tilray’s stock is valued at $17.02 at 20:35 EST, way below its 52-week high of $67.00 and way higher than its 52-week low of $4.41.

Tilray’s Moving Average

Tilray’s worth is way under its 50-day moving average of $25.35 and way above its 200-day moving average of $14.55.

Previous days news about Tilray

Tilray shareholders approve Aphria merger, creating world's biggest cannabis company by revenue. According to MarketWatch on Sunday, 2 May, " Under the terms of the proposed deal, Aphria shareholders will receive 0.8381 of a Tilray share of class 2 common stock for each Aphria share owned. "

Tilray says shares will start trading on toronto stock exchange from May 5 after Aphria merger approved. According to MarketWatch on Monday, 3 May, "Canadian cannabis company Tilray Inc. said Monday its shares will continue to trade on Nasdaq under the ticker symbol "TLRY" after its merger with fellow Canadian cannabis company Aphria Inc. which shareholders approved on Friday, and will start to trade on the Toronto Stock Exchange under the same ticker from May 5. "

More news about Tilray.

LEAVE A REPLY

Please enter your comment!
Please enter your name here